We are live on ! Find out more
FDMT icon

4D Molecular Therapeutics
FDMT

96 hedge funds and large institutions have $622M invested in 4D Molecular Therapeutics in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 25 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

181% more capital invested

Capital invested by funds: $221M → $622M (+$401M)

179% more call options, than puts

Call options by funds: $2.74M | Put options by funds: $981K

40% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 20

9% more funds holding

Funds holding: 88 → 96 (+8)

1.54% more ownership

Funds ownership: 84.9% → 86.45% (+1.5%)

24% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 33

Holders
96
Holders Change
+8
Holders Change %
+9.09%
% of All Funds
1.54%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
28
Increased
25
Reduced
33
Closed
20
Calls
$2.74M
Puts
$981K
Net Calls
+$1.76M
Net Calls Change
+$997K

Top Buyers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$11.9M
2
CC
Casdin Capital
New York
+$9.73M
3
CC
Commodore Capital
New York
+$9.24M
4
State Street
State Street
Massachusetts
+$8.62M
5
Norges Bank
Norges Bank
Norway
+$4.54M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$18.1M
2
Morgan Stanley
Morgan Stanley
New York
-$8.7M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$8.46M
4
DTC
Deep Track Capital
Connecticut
-$8.34M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$4.21M +$2.77M +179,345 +1,786%
Two Sigma Investments
27
Two Sigma Investments
New York
$3.42M +$2.12M +137,525 +836%
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$3.09M -$2.47M -159,700 -53%
N
29
Nuveen
North Carolina
$2.87M -$264K -17,104 -12%
Renaissance Technologies
30
Renaissance Technologies
New York
$2.85M +$911K +59,000 +85%
Goldman Sachs
31
Goldman Sachs
New York
$2.63M +$205K +13,274 +13%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.44M +$41.6K +2,693 +3%
Bank of America
33
Bank of America
North Carolina
$1.72M +$888K +57,509 +289%
Deutsche Bank
34
Deutsche Bank
Germany
$1.67M +$25.5K +1,649 +2%
Marshall Wace
35
Marshall Wace
United Kingdom
$1.55M +$1.08M +69,747 New
Squarepoint
36
Squarepoint
New York
$1.38M +$960K +62,126 New
SAM
37
Sectoral Asset Management
Quebec, Canada
$1.2M +$832K +53,836 New
Vontobel Holding
38
Vontobel Holding
Switzerland
$1.2M +$832K +53,836 New
Connor, Clark & Lunn Investment Management (CC&L)
39
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.07M +$744K +48,198 New
Rafferty Asset Management
40
Rafferty Asset Management
New York
$1.06M +$740K +47,933 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.05M +$32K +2,070 +5%
BCM
42
Bridgeway Capital Management
Texas
$942K -$232K -15,000 -26%
UBS Group
43
UBS Group
Switzerland
$905K +$629K +40,728 New
PWS
44
Peloton Wealth Strategists
Indiana
$822K -$216K -14,000 -27%
Jane Street
45
Jane Street
New York
$806K +$561K +36,306 New
Barclays
46
Barclays
United Kingdom
$770K +$360K +23,297 +205%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$716K +$335K +21,668 +205%
Fidelity Investments
48
Fidelity Investments
Massachusetts
$597K -$4.04M -261,302 -91%
Citigroup
49
Citigroup
New York
$573K +$246K +15,922 +161%
M&T Bank
50
M&T Bank
New York
$522K -$536K -34,712 -60%
1
2
3 4 5

FDMT Hedge Fund Activity: Q4 2022 in Review

96 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in 4D Molecular Therapeutics (FDMT) for Q4 2022, worth a combined $622M — up 181% from $221M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new FDMT positions and 20 closed out — a net gain of 8 holders — while 25 added to existing stakes and 33 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $11.9M. The largest seller was Janus Henderson Group, cutting an estimated $18.1M.

  • 96 institutional investors held 4D Molecular Therapeutics (FDMT) as of Q4 2022, up from 88 in Q3 2022.
  • Funds reported $622M of 4D Molecular Therapeutics stock for Q4 2022, up 181% quarter-over-quarter.
  • 28 funds opened new 4D Molecular Therapeutics positions in Q4 2022 and 20 closed out, a net change of +8 holders.
  • The largest 4D Molecular Therapeutics buyer in Q4 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $11.9M added.
  • The largest 4D Molecular Therapeutics seller in Q4 2022 was Janus Henderson Group, an estimated $18.1M sold.

Based on aggregated 13F filings for Q4 2022.